Trial Profile
Impact of Atorvastatin on the Distribution, Composition, and Metabolism of LDL and HDL Subfractions: A Double-Blind Placebo-Controlled Phase IV Study With Patients Suffering From Combined Hyperlipidemia and Diabetes. Atorvastatin and LDL Profile in NIDDM (ALPIN Study)
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary)
- Indications Hyperlipidaemia
- Focus Therapeutic Use
- Acronyms ALPIN
- Sponsors Pfizer
- 05 Nov 2010 New trial record.